Eliem Therapeutics, Inc.

Eliem Therapeutics, Inc.verified

ELYM

Price:

$8.25

Market Cap:

$228.72M

Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Its two lead drug candidates are ETX-810 for chronic pain, which is in Phase IIa clinical trial; and ETX-155 for the treatment of major depressive disorder, perimenopausal depression, and focal onset seizures that is in Phase I clinical trial. The company also develops preclinical pipeline programs, such as Kv7 Program for pain, epilepsy, and depression; and Anxiolytic for the treatment of generalized anxiety disorder. Eliem The...[Read more]

Industry

Biotechnology

IPO Date

2021-08-10

Stock Exchange

NASDAQ

Ticker

ELYM

The PE Ratio as of May 2024 (TTM) for Eliem Therapeutics, Inc. (ELYM) is -6.35

According to Eliem Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -6.35. This represents a change of 3.16% compared to the average of -6.16 of the last 4 quarters.

Eliem Therapeutics, Inc. (ELYM) Historical PE Ratio (quarterly & annually)

How has ELYM PE Ratio performed in the past?

The mean historical PE Ratio of Eliem Therapeutics, Inc. over the last ten years is -31.31. The current -6.35 PE Ratio has changed 1.93% with respect to the historical average. Over the past ten years (40 quarters), ELYM's PE Ratio was at its highest in in the March 2023 quarter at -0.91. The PE Ratio was at its lowest in in the June 2020 quarter at -28.42.

Quarterly (TTM)
Annual

Average

-31.31

Median

-5.78

Minimum

-110.21

Maximum

-2.07

Eliem Therapeutics, Inc. (ELYM) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Eliem Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual PE Ratio = -2.07

Minimum Annual Increase = -84.10%

Minimum Annual PE Ratio = -110.21

Quarterly (TTM)
Annual
YearPE RatioChange
2023-2.07-2.55%
2022-2.13-63.16%
2021-5.78-84.10%
2020-36.36-67.01%

Eliem Therapeutics, Inc. (ELYM) Average PE Ratio

How has ELYM PE Ratio performed in the past?

The current PE Ratio of Eliem Therapeutics, Inc. (ELYM) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-3.33

5-year avg

-31.31

10-year avg

-31.31

Eliem Therapeutics, Inc. (ELYM) PE Ratio vs. Peers

How is ELYM’s PE Ratio compared to its peers?

Eliem Therapeutics, Inc.’s PE Ratio is less than PMV Pharmaceuticals, Inc. (-1.66), greater than MediciNova, Inc. (-8.28), greater than Pharvaris N.V. (-12.17), less than PepGen Inc. (-4.69), greater than Anebulo Pharmaceuticals, Inc. (-6.38), less than Rezolute, Inc. (-2.30), less than HCW Biologics Inc. (-1.49), less than Molecular Partners AG (-1.93), greater than Aerovate Therapeutics, Inc. (-6.96), less than Adagene Inc. (-3.91), less than Acrivon Therapeutics, Inc. Common Stock (-3.13), less than AN2 Therapeutics, Inc. (-1.02), less than Cyteir Therapeutics, Inc. (-3.52), less than Pardes Biosciences, Inc. (-1.36), less than Shattuck Labs, Inc. (-4.70), greater than Champions Oncology, Inc. (-6.57), less than Century Therapeutics, Inc. (-1.40),

Build a custom stock screener for Eliem Therapeutics, Inc. (ELYM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Eliem Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Eliem Therapeutics, Inc. (ELYM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Eliem Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Eliem Therapeutics, Inc.'s PE Ratio?

How is the PE Ratio calculated for Eliem Therapeutics, Inc. (ELYM)?

What is the highest PE Ratio for Eliem Therapeutics, Inc. (ELYM)?

What is the 3-year average PE Ratio for Eliem Therapeutics, Inc. (ELYM)?

What is the 5-year average PE Ratio for Eliem Therapeutics, Inc. (ELYM)?

How does the current PE Ratio for Eliem Therapeutics, Inc. (ELYM) compare to its historical average?